Giant adrenal metastasis of malignant melanoma: impact of 18F-FDG PET/CT in early assessment of dramatic response to immunotherapy: case report

F Kalantari, G Schweighofer-Zwink (Co-Autor/-in), G Rendl (Co-Autor/-in), C Pirich (Co-Autor/-in), M Beheshti* (Letztautor/-in)

*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in FachzeitschriftFallberichtBegutachtung

Abstract

BackgroundThis case represents one of the largest adrenal metastases in the literature and highlights the importance of accurate imaging in clinical management of patients with advanced malignant melanoma.Case presentationA 67-year-old female with an ulcerated malignant melanoma presented with an asymptomatic 18-cm left adrenal mass on 18F-FDG PET/CT staging. After two cycles of combined systemic immunotherapy, an impressive shrinkage of the adrenal metastatic tumor was observed on 18F-FDG PET/CT imaging.ConclusionsThe case emphasizes the potential of 18F-FDG PET/CT as a functional imaging modality for accurate staging and precise early assessment of response to immunotherapy. Overall, this report highlights the importance of accurate imaging for the effective management of adrenal metastases in melanoma patients.
OriginalspracheEnglisch
Aufsatznummer158
Seitenumfang3
FachzeitschriftEGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE
Jahrgang54
Ausgabenummer1
DOIs
PublikationsstatusVeröffentlicht - 20 Sept. 2023

Fingerprint

Untersuchen Sie die Forschungsthemen von „Giant adrenal metastasis of malignant melanoma: impact of 18F-FDG PET/CT in early assessment of dramatic response to immunotherapy: case report“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren